Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.

Kassan A, Egawa J, Zhang Z, Almenar-Queralt A, Nguyen QM, Lajevardi Y, Kim K, Posadas E, Jeste DV, Roth DM, Patel PM, Patel HH, Head BP.

J Neurophysiol. 2017 Jan 1;117(1):436-444. doi: 10.1152/jn.00481.2016. Epub 2016 Nov 2.

PMID:
27832597
2.

SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex.

Tankou S, Ishii K, Elliott C, Yalla KC, Day JP, Furukori K, Kubo KI, Brandon NJ, Tang Q, Hayward G, Nakajima K, Houslay MD, Kamiya A, Baillie G, Ishizuka K, Sawa A.

Mol Neuropsychiatry. 2016 May;2(1):20-27. Epub 2016 Mar 15.

PMID:
27525255
3.

DISC1 as a Possible Genetic Contribution to Opioid Dependence in a Polish Sample.

Fudalej S, Jakubczyk A, Kopera M, Piwonski J, Bielecki W, Drygas W, Wasilewska K, Ilgen M, Bohnert A, Barry K, Płoski R, Blow FC, Wojnar M.

J Stud Alcohol Drugs. 2016 Mar;77(2):220-6.

4.

DISC1 signaling in cocaine addiction: Towards molecular mechanisms of co-morbidity.

Gancarz A, Jouroukhin Y, Saito A, Shevelkin A, Mueller LE, Kamiya A, Dietz DM, Pletnikov MV.

Neurosci Res. 2016 Apr;105:70-4. doi: 10.1016/j.neures.2015.09.001. Epub 2015 Sep 15.

PMID:
26385055
5.

Postmortem brain: an underutilized substrate for studying severe mental illness.

McCullumsmith RE, Hammond JH, Shan D, Meador-Woodruff JH.

Neuropsychopharmacology. 2014 Jan;39(1):65-87. doi: 10.1038/npp.2013.239. Epub 2013 Oct 4. Review. Erratum in: Neuropsychopharmacology. 2015 Apr;40(5):1307.

6.

Construction of photoenergetic mitochondria in cultured mammalian cells.

Hara KY, Wada T, Kino K, Asahi T, Sawamura N.

Sci Rep. 2013;3:1635. doi: 10.1038/srep01635.

7.

DISC1 genetics, biology and psychiatric illness.

Thomson PA, Malavasi EL, Grünewald E, Soares DC, Borkowska M, Millar JK.

Front Biol (Beijing). 2013 Feb 1;8(1):1-31.

8.

The inverse F-BAR domain protein srGAP2 acts through srGAP3 to modulate neuronal differentiation and neurite outgrowth of mouse neuroblastoma cells.

Ma Y, Mi YJ, Dai YK, Fu HL, Cui DX, Jin WL.

PLoS One. 2013;8(3):e57865. doi: 10.1371/journal.pone.0057865. Epub 2013 Mar 7.

9.

A Disc1 mutation differentially affects neurites and spines in hippocampal and cortical neurons.

Lepagnol-Bestel AM, Kvajo M, Karayiorgou M, Simonneau M, Gogos JA.

Mol Cell Neurosci. 2013 May;54:84-92. doi: 10.1016/j.mcn.2013.01.006. Epub 2013 Feb 6.

10.

DISC1 as a therapeutic target for mental illnesses.

Hikida T, Gamo NJ, Sawa A.

Expert Opin Ther Targets. 2012 Dec;16(12):1151-60. doi: 10.1517/14728222.2012.719879. Epub 2012 Nov 6. Review.

11.

Interactions of human truncated DISC1 proteins: implications for schizophrenia.

Newburn EN, Hyde TM, Ye T, Morita Y, Weinberger DR, Kleinman JE, Lipska BK.

Transl Psychiatry. 2011 Aug 16;1:e30. doi: 10.1038/tp.2011.31.

12.

Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.

Schlaak JF, Trippler M, Hoyo-Becerra C, Erim Y, Kis B, Wang B, Scherbaum N, Gerken G.

PLoS One. 2012;7(6):e38668. doi: 10.1371/journal.pone.0038668. Epub 2012 Jun 6.

13.

AKT/GSK3 signaling pathway and schizophrenia.

Emamian ES.

Front Mol Neurosci. 2012 Mar 15;5:33. doi: 10.3389/fnmol.2012.00033. eCollection 2012 Mar 15.

14.

Linking neurodevelopmental and synaptic theories of mental illness through DISC1.

Brandon NJ, Sawa A.

Nat Rev Neurosci. 2011 Nov 18;12(12):707-22. doi: 10.1038/nrn3120. Review.

15.

Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.

Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan Y, Yang C, Taniguchi Y, Abazyan B, Valentine H, Krasnova IN, Kamiya A, Cadet JL, Wong DF, Pletnikov MV.

Neuropharmacology. 2012 Mar;62(3):1242-51. doi: 10.1016/j.neuropharm.2011.02.003. Epub 2011 Feb 17.

16.

Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade.

Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, Stanco A, Eom TY, Rao S, Ishizuka K, Wong P, Korth C, Anton ES, Sawa A.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5622-7. doi: 10.1073/pnas.0909284107. Epub 2010 Mar 8.

17.

DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms.

Nakata K, Lipska BK, Hyde TM, Ye T, Newburn EN, Morita Y, Vakkalanka R, Barenboim M, Sei Y, Weinberger DR, Kleinman JE.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15873-8. doi: 10.1073/pnas.0903413106. Epub 2009 Sep 2.

18.

Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A.

Trends Neurosci. 2009 Sep;32(9):485-95. doi: 10.1016/j.tins.2009.05.007. Epub 2009 Aug 26. Review.

19.

Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation.

Drerup CM, Wiora HM, Topczewski J, Morris JA.

Development. 2009 Aug;136(15):2623-32. doi: 10.1242/dev.030577. Epub 2009 Jul 1.

20.

Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs.

Homayoun H, Moghaddam B.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):18041-6. doi: 10.1073/pnas.0806669105. Epub 2008 Nov 12.

Supplemental Content

Support Center